Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
2(40%)

Phase Distribution

Ph phase_1
1
20%
Ph phase_3
1
20%
Ph phase_2
2
40%
Ph not_applicable
1
20%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)

Detailed Status

Completed2
Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 31 (20.0%)
N/A1 (20.0%)

Trials by Status

completed240%
active_not_recruiting120%
terminated240%

Recent Activity

1 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis

NCT07186478
terminatedphase_2

A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

NCT00040391
completedphase_2

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

NCT00034957
terminatedphase_3

The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease

NCT00006187
completedphase_1

Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma

NCT00036140

Clinical Trials (5)

Showing 5 of 5 trials
NCT07186478Not Applicable

I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis

Active Not Recruiting
NCT00040391Phase 2

A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

Terminated
NCT00034957Phase 2

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

Completed
NCT00006187Phase 3

The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease

Terminated
NCT00036140Phase 1

Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5